Tandem Diabetes Care | TNDM - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 23.39B 2025-09
Accuray USD 100K 1000 2024-09
Align Technology USD 71.62M 133K 2026-03
AtriCure USD 49.79M 91K 2025-12
Baxter International USD 516.45M 2.17M 2026-03
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.11M 14K 2026-03
Dexcom USD 385.9M 1.1M 2026-03
Edwards Lifesciences USD 580.7M 0 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Globus Medical USD 135.06M 449K 2025-12
ICU Medical USD 24.69M 2K 2025-12
Inogen USD 23K 0 2023-12
Insulet USD 69.26M 1.08M 2026-03
Integra LifeSciences USD 77.82M 69K 2026-03
Intuitive Surgical USD 355.17M 674K 2026-03
J&J USD 2.41B 1.74M 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.65M 231K 2026-03
Orthofix International USD 39.83M 315K 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
Stryker USD 382.98M 584K 2026-03
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.26M 70K 2026-03
Zimmer Biomet Holdings USD 195.5M 2.68M 2026-03